Skip to main content
. 2020 Aug 10;9(19):6996–7006. doi: 10.1002/cam4.3364

TABLE 1.

Characteristics of patients with spinal cord astrocytomas who were enrolled in the study

All patients (N = 108) Low‐grade (N = 54) High‐grade (N = 54) P‐value a
Variable N (%) N (%) N (%)
Age (y) Median (range) 30.0 (4‐63) 27.0 (4‐54) 35.5 (8‐63) .001
Sex Female 41 (38.0%) 16 (29.6%) 25 (46.3%) .074
Male 67 (62.0%) 38 (70.4%) 29 (53.7%)
Location C 40 (37.0%) 21 (38.9%) 19 (35.2%) .896
C‐T 16 (14.8%) 8 (14.8%) 8 (14.8%)
T 44 (40.8%) 22 (40.7%) 22 (40.7%)
T‐L 8 (7.4%) 3 (5.6%) 5 (9.3%)
Segment length Average 3.91 3.78 4.04 .434
Resection GTR 58 (53.7%) 35 (64.8%) 23 (42.6%) .054
STR 18 (16.7%) 8 (14.8%) 10 (18.5%)
OB 32 (29.6%) 11 (20.4%) 21 (38.9%)
Presurgery MMS 1 4 (3.7%) 3 (5.7%) 1 (1.9%) <.001
2 50 (46.7%) 37 (69.8%) 13 (24.1%)
3 36 (33.6%) 10 (18.9%) 26 (48.1%)
4 17 (15.9%) 3 (5.7%) 14 (25.9%)
NA 1 1 0
Postsurgery MMS 1 5 (4.7%) 4 (7.5%) 1 (1.9%) <.001
2 39 (36.4%) 31 (58.5%) 8 (14.8%)
3 44 (41.1%) 16 (30.2%) 28 (51.9%)
4 19 (17.8%) 2 (3.8%) 17 (31.5%)
NA 1 1 0
Radiotherapy Yes 62 (67.4%) 32 (66.7%) 30 (68.2%) .877
No 30 (32.6%) 16 (33.3%) 14 (31.8%)
NA 16 6 10
Chemotherapy Yes 27 (29.3%) 8 (16.7%) 19 (43.2%) .005
No 65 (70.7%) 40 (83.3%) 25 (56.8%)
NA 16 6 10
Ki‐67 <10% 53 (51.0%) 42 (82.4%) 11 (20.8%) <.001
≥10% 51 (49.0%) 9 (19.6%) 42 (79.2%)
NA 4 3 1
H3 K27M Negative 62 (62.0%) 15 (28.3%)
Positive 38 (38.0%) 38 (71.7%)
NA 8 b 7 1

Note: Significance of bold values P < .05.

Abbreviations: C, cervical; C‐T, cervicothoracic; GTR, gross total resection; MMS, Modified McCormick Scale; NA, not available; OB, open biopsy; STR, subtotal resection; T, thoracic; T‐L, thoracolumbar.

a

P‐values for the t test or Chi‐squared test or Mann‐Whitney U test used to compare low‐grade and high‐grade tumors.

b

Patients before 2016 without data on H3 K27M mutation and without adequate tissue sample available for added immunohistochemistry, including 2, 5, and 1 patient with grade I, II, and III tumors, respectively.